Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04849637Phase 2Unknown
Phase 2, randomised, open-label trial (2 arms), sponsored by University of the Philippines. Primary endpoints: Duration of hospital stay at 2 weeks and Time to recovery/resolution of symptoms at 2 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04849637.